[Clinicoimmunological features and treatment of acute intestinal infection of Proteus etiology].
Iushchuk
N D
ND
MMSI of NA Semashko.
Frolov
V M
VM
Peresadin
N A
NA
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000293:Adolescent; D000328:Adult; D000368:Aged; D000975:Antioxidants / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004760:Enterocolitis / Q000188:drug therapy* / Q000276:immunology* / Q000382:microbiology; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use*; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D008875:Middle Aged; D011511:Proteus / Q000302:isolation & purification*; D011512:Proteus Infections / Q000188:drug therapy* / Q000276:immunology* / Q000382:microbiology; D011994:Recombinant Proteins
D000276:Adjuvants, Immunologic; D000975:Antioxidants; D007370:Interferon Type I; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins